CTNNB1 and endometrial carcinoma: CTNNB1 mutations, particularly those located in exon 3 of the CTNNB1 gene encoding β-catenin, have emerged as significant factors influencing the clinicopathologic features and prognostic outcomes in endometrial carcinoma.